Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Postoperative Adjuvant Chemotherapy in Early-stage Cervical Cancer That Not Meet Criteria of Adjuvant Therapeutic According to NCCN Guideline: A Prospective Multicenter Randomized Controlled Clinical Trial

NCT04723875 is registered in ClinicalTrials.gov with Huazhong University of Science and Technology as lead sponsor.

NCT NCT04723875
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04723875 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Postoperative Adjuvant Chemotherapy in Early-stage Cervical Cancer That Not Meet Criteria of Adjuvant Therapeutic According to NCCN Guideline: A Prospective Multicenter Randomized Controlled Clinical Trial
Lead sponsor
Huazhong University of Science and Technology
Phase
Phase 3
Overall status
Active, not recruiting
Start date
January 28, 2021
Completion date
January 31, 2026
Enrollment
306 (estimated)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

cervical cancer, uterine cervical neoplasms